Within a newly established consortium, Immunetune will develop enhanced DNA vaccines against SARS-CoV-2 and other human coronaviruses. The vaccine is built on the combination of two strong synthetic vaccine platforms and the inclusion of conserved T and B cell epitopes to provide both humoral and cellular defenses against Covid-19 and possible future outbreaks of coronaviruses. The consortium is financially supported by Health Holland.
Immunetune featured as one of the #DutchTechHeroes Fighting COVID-19
Immunetune featured as one of the #DutchTechHeroes Fighting COVID-19
